NEW YORK (GenomeWeb) – Synthego — a Bay Area-based biotech startup aiming to automate and scale up genome engineering research — today announced it has raised $41 million in a Series B financing round.

AME Cloud Ventures, Elements Capital, OS Fund, Alexandria Equities, ZhenFund, and University of California, Berkeley CRISPR researcher Jennifer Doudna joined the round as new investors, which was led by venture capital firm 8VC. Existing investors Founders Fund, Menlo Ventures, WI Harper Group, and SciFi VC also participated.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Jay Shendure and his colleagues have developed a new method to more comprehensively identify human cell types, the NY Times reports.

Researchers in the UK and Japan have shown that infertility in mice with three sex chromosomes can be overcome, according to the Guardian.

China is embracing preimplantation genetic diagnosis, Nature News reports. 

In PLOS this week: host genetic factors associated with cervical neoplasia progression, population patterns for an ancient flowering rainforest plant, and more.